Financing ·
On July 14, 2026, Avantor Funding, Inc., a subsidiary of Avantor, Inc., entered into Amendment No. 15 to its Credit…
AVTRAvantor, Inc.
On July 14, 2026, Avantor Funding, Inc., a subsidiary of Avantor, Inc., entered into Amendment No. 15 to its Credit Agreement to obtain €374,208,296.62 in senior secured Euro-denominated term loans (Incremental B-7 Euro Term Loans). These loans, maturing October 9, 2032, carry an interest rate of the floating EURIBOR Rate plus 2.00% per annum, effectively refinancing existing euro term loans that carried a higher spread of 2.50%. The new loans are secured by the same collateral and guaranteed by the same subsidiaries as the existing credit facilities. Avantor operates in the life sciences industry, providing products and services to customers in the biopharma, healthcare, education, and government sectors.